ORAGRAFIN SODIUM
LOE ApproachingNDAORALCAPSULEPriority Review
Approved
Jun 1962
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Priority Review
Drug data last refreshed 19h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
ORAGRAFIN SODIUM is an oral capsule diagnostic agent approved in 1962 by Bracco for radiographic imaging procedures. The specific mechanism of action and clinical indications are not publicly documented in this dataset, but it represents a legacy radiographic contrast product from the early diagnostic imaging era. This product is now approaching loss of exclusivity.
LOE Approaching
As a legacy product approaching LOE with minimal documented commercial activity, the brand team is likely small and focused on managed decline or niche market retention.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on ORAGRAFIN SODIUM offers minimal career growth potential given its mature, declining lifecycle stage and zero linked job openings. This role would be suited only to professionals seeking stability in legacy product management or transition roles within Bracco's broader portfolio.
Product Manager (Specialty/Legacy)Regulatory Affairs
Worked on ORAGRAFIN SODIUM at Bracco? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.